Abstract 1878P
Background
The growing number of patients with genitourinary cancers (GU) could create an increasing burden on GU oncologists. Bureau for Cancer Research (BUCARE) describes the prevalence of burnout in GU oncologists in Central Asia region.
Methods
This is a cross-sectional survey study conducted among practicing cancer care physicians (surgical, medical, radiation) at the ASCO / Asian American GU Symposium ( Almaty, April 2023 ). The primary outcome was burnout experience assessed through the Maslach Burnout Inventory.
Results
A total of 101 oncologists completed the questionnaire. Table summarizes physician's characteristics. Despite the fact that 100% of responders are interested in their work, 66% (67 of 101) had symptoms of burnout (high emotional exhaustion and/or depersonalization scores). Fifty percent of oncologists are ready to turn to a psychologist for help. Significant drivers of burnout identified in multivariable regression modeling included ³20 patients per day (odds ratio [OR] = 14.8; P<0.001) and ³10 working hours per day (OR=8.6; P<0.001). Male gender (OR=0.14; P<0.001) and specialization in radiation therapy (OR=0.20; P<0.01) were associated with lower odds of burnout.
Conclusions
More than half of participants met predefined standardized criteria for burnout. Expanding the staff of GU oncologists and reducing the daily workload may improve the emotional state of physicians. Table: 1878P
Characteristics | N=101 |
Gender, N (%) | |
Female | 68 (67.3) |
Male | 33 (37.7) |
Region, N (%) | |
Kazakhstan | 85 (84.2) |
Other countries | 17 (16.8) |
Specialty, N (%) | |
Surgery | 39 (38.6) |
Medical Oncology | 44 (43.6) |
Radiation Oncology | 18 (17.8) |
Department, N (%) | |
In-patient | 79 (78.2) |
Out-patient | 22 (21.8) |
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1594P - End-of-life hospital cancer care in the COVID-19 era: A retrospective population-based study in the Netherlands
Presenter: Ellis Slotman
Session: Poster session 05
1595P - Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience
Presenter: Silvia Buriolla
Session: Poster session 05
1596P - Exploring the economic impact of palliative care in oncology at the end of life
Presenter: Sarah Gomes
Session: Poster session 05
1597P - Improving in-hospital end-of-life care (EOLC) for oncology patients in a tertiary cancer centre
Presenter: Conor Moloney
Session: Poster session 05
1598P - Differences in referral patterns to the palliative care team among specialized physicians in patients with terminal cancer
Presenter: Hyun Jeong Shim
Session: Poster session 05
1599P - Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study
Presenter: Alessandro Leonetti
Session: Poster session 05
1600P - Sarcopenia, depression, and poor health perception among cancer patients registered in an oncology center in Pakistan
Presenter: Sobia Yaqub
Session: Poster session 05
1601P - Relationship between CT and ultrasonography-based sarcopenia and hematologic toxicity in patients with cancer receiving chemotherapy
Presenter: Gurkan Guner
Session: Poster session 05
1602P - Simulation training for compassionate extubation in the pediatric intensive care unit
Presenter: Nicole Fernandez
Session: Poster session 05
1603P - The ability of the LACE index to predict 30-day readmissions in oncology patients
Presenter: Burcu Ulas Kahya
Session: Poster session 05